Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05380245Phase 4Completed
Phase 4, randomised, open-label trial of voriconazole in fungal infection (2 arms), sponsored by Abdul Wali Khan University Mardan. Primary endpoints: Plasma Concentration of voriconazole at 24 hours and Area under the Plasma Concentration versus Time Curve at 24 hours. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05380245.